Nivolumab/Ipilimumab Plus Cabozantinib in Patients With Unresectable Advanced Melanoma
Clinical trial NCT04091750 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04091750
- Sponsor
- Georgetown University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-02
- Primary completion
- 2023-08-08
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.